India, May 21 -- While reporting financial results for the fourth quarter on Wednesday, medical devices maker Medtronic plc (MDT) initiated its adjusted earnings and organic revenue growth guidance for the full-year 2026, excluding the potential impacts from increased tariffs.
For fiscal 2026, the company now projects adjusted earnings in a range of $5.50 to $5.60 per share on revenue growth of 4.8 to 5.1 percent, with organic revenue growth of about 5.0 percent.
On average, analysts polled expect the company to report earnings of $5.83 per share on revenue growth of 4.5 percent to $35.01 billion for the year. Analysts' estimates typically exclude special items.
The company said the lower end of the range assumes that the bilateral US/Ch...